Evidence map›Paper›PMID 33559133›Full record

Observational studyJournal of surgical oncology2021

Evaluating the feasibility of performing elective gastrointestinal cancer surgery during the COVID-19 pandemic: An observational study with 60 days follow-up results of a tertiary referral pandemic hospital.

Alper Sozutek, Ahmet Seker, Adnan Kuvvetli, Nazmi Ozer, Ismail Caner Genc

Abstract readObservational Study
In one paragraph

Observational study in Journal of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alper SozutekDivision of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.ORCID http://orcid.org/0000-0003-1039-9011
Ahmet SekerDivision of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.
Adnan KuvvetliDivision of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.
Nazmi OzerDivision of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.
Ismail Caner GencDivision of Gastroenterological Surgery, Department of General Surgery, Adana City Training and Research Hospital, Health Sciences University, Adana, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) pandemic has interfered with the treatment algorithm for patients with gastrointestinal (GIS) cancer, resulting in deferral of surgery. We presented the outcomes of our patients to evaluate whether surgery could be safely performed and followed-up without delaying any stage of GIS cancer during the pandemic.

methodsThis was an observational study of 177 consecutive patients who underwent elective GIS cancer surgery between March 11 and November 1, 2020. They were assessed regarding their perioperative and 60 days follow-up results for either surgical or COVID-19 status. Morbidity was determined according to the Clavien-Dindo classification (CDC). Continuous and categorical data were presented as median ± SD and number with percentage (%), respectively.

resultsThe study included 44 gastric, 33 pancreatic, 40 colon, and 59 rectal cancer patients. All patients underwent surgery and received neo/adjuvant treatments without delay. The overall morbidity (CDC grade II-IV) and mortality rates were 10.1% and 3.9%, respectively. None of the patients or medical staff were infected with COVID-19 during the study period.

conclusionGIS cancer surgery can be safely performed even within a pandemic hospital if proper isolation measures can be achieved for both patients and health workers. Regardless of the tumor stage, surgery should not be deferred, depending on unstandardized algorithms.

Indexed as

AdultAgedCOVID-19Elective Surgical ProceduresFeasibility StudiesFemaleFollow-Up StudiesGastrointestinal NeoplasmsHumansInfection ControlLength of StayMaleMiddle AgedOperative TimePatient SelectionPostoperative ComplicationsCOVID-19delaygastrointestinal cancersoncologic surgerysurgical outcomes

Identifiers

PMID33559133
PMCPMC8013399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.